메인으로

Company Introduction

Drug discovery and development company in the field of oncology and other rare diseases

  • home icon

ABOUT US

ONCOBIX is working toward developing innovative therapies for rare and incurable diseases with challenging treatments.

Non-small cell lung cancer (NSCLC), which accounts for 85% of lung cancer cases worldwide, has been on an upward trend since 2000 due to air pollution, chemical products, and genetic mutations. Notably, 10-15% of all lung cancer patients have developed resistance to conventional drugs and now suffer without standard treatment. With our own platform technology, ONCOBIX aims to overcome this resistance to currently available treatments. We have established pipelines to study and develop globally competitive fourth-generation drugs for NSCLC and pulmonary fibrosis. Our promise is to contribute to the health and well-being of humanity, delivering a better quality of life and longevity to patients suffering from diseases.

MISSION & VISION

With the innovative TOFPOMICS® platform technology, we present solutions to diseases without standard treatment, becoming a global leader in innovative drug discovery and contributing to the health and well-being of humanity.

  • Mission

    Developing innovative new drugs
    based on platform technology
    to contribute to the health
    and well-being of humanity

  • Vision

    Presenting solutions to unmet needs
    of rare, incurable diseases

Philosophy

Talents

  • People who share the same objectives, collaborate, and have a growth mindset

  • People who take on challenges with innovative thinking

  • People who prioritize integrity and ethics

We all live in this world as one of the life want to live

Will you make your friend a living hope or a lifeless disappointment?

회원로그인

회원가입